title: Sequencing of combined hyperthermia and photodynamic therapy.
abstract: Photodynamic therapy (PDT) and hyperthermia are two alternative tumor treatment modalities currently being investigated in clinical trials. It has been suggested that, due to the differences in cell-killing mechanisms, synergetic tumor responses may be achieved if the two modalities are combined in appropriate sequences. This hypothesis is tested in the current study by delivering graded PDT doses during a transient tumor reoxygenation period after a hyperthermia treatment, or delivering graded hyperthermia doses when the tumor becomes acidic and hypoxic after a PDT treatment. The results indicate that the latter combination sequence has a profound effect on tumor response. While treating the tumors with PDT followed by hyperthermia evokes a synergetic tumor response, reversing the sequence results only in an additive effect. Possible mechanisms associated with tissue oxygenation are discussed.
authors: Research and Development, HealthONE, Denver, Colorado 80218, USA.
authors: Q
authors: Q
authors: Chen
authors: H
authors: H
authors: Chen
authors: H
authors: H
authors: Shapiro
authors: F W
authors: FW
authors: Hetzel
mesh_terms: D000818:Animals; D003131:Combined Modality Therapy; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use*; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006414:Hematoporphyrin Photoradiation; D006979:Hyperthermia, Induced; D008027:Light; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000503:physiopathology / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D010100:Oxygen / Q000032:analysis; D010313:Partial Pressure; D013997:Time Factors
chemical_list: D017323:Dihematoporphyrin Ether; D010100:Oxygen